Inventor · disambiguated record
Dennis E. Hallahan
Also filed as: HALLAHAN DENNIS · HALLAHAN DENNIS E
34 granted patents·13 pending applications·631 citations·filing 1992–2022
98Inventor score
Top patents by PatentIndex Score
47 records- 0194US8101157B2Ligands to radiation-induced moleculesHALLAHAN DENNIS E·Filed 2006·Granted Jan 24, 2012·13 cites·14 claims
- 0293US8388932B2Ligands to radiation-induced moleculesHALLAHAN DENNIS E·Filed 2011·Granted Mar 5, 2013·11 cites·17 claims
- 0393US7968675B2In vivo panning for ligands to radiation-induced moleculesUNIV VANDERBILT·Filed 2008·Granted Jun 28, 2011·12 cites·22 claims
- 0493US7049140B1X-ray guided drug deliveryUNIV VANDERBILT·Filed 2000·Granted May 23, 2006·39 cites·47 claims
- 0592US8771754B2Use of GSK3 inhibitors in combination with radiation therapiesHALLAHAN DENNIS E·Filed 2005·Granted Jul 8, 2014·23 cites·35 claims
- 0692US8765097B2Ligands to radiation-induced moleculesHALLAHAN DENNIS E·Filed 2013·Granted Jul 1, 2014·8 cites·17 claims
- 0792US8012945B2Phage antibodies to radiation-inducible neoantigensUNIV VANDERBILT·Filed 2007·Granted Sep 6, 2011·10 cites·13 claims
- 0892US7906102B2Ligands to radiation-induced moleculesUNIV VANDERBILT·Filed 2005·Granted Mar 15, 2011·15 cites·34 claims
- 0992US7306925B2Phage antibodies to radiation-inducible neoantigensUNIV VANDERBILT·Filed 2003·Granted Dec 11, 2007·23 cites·24 claims
- 1091US9340581B2Ligands to radiation-induced moleculesHALLAHAN DENNIS E·Filed 2014·Granted May 17, 2016·6 cites·13 claims
- 1191US6159443AX-ray guided drug deliveryUNIV VANDERBILT·Filed 1999·Granted Dec 12, 2000·95 cites·104 claims
- 1291US5770581AGene transcription and ionizing radiation: methods and compositionsARCH DEV CORP·Filed 1995·Granted Jun 23, 1998·74 cites·15 claims
- 1391US5612318AControl of gene expression by ionizing radiationFiled 1994·Granted Mar 18, 1997·76 cites·8 claims
- 1489US10259884B2Antibodies to GRP78UNIV WASHINGTON·Filed 2017·Granted Apr 16, 2019·6 cites·9 claims
- 1589US8927288B2Phage antibodies to radiation-inducible neoantigensUNIV VANDERBILT·Filed 2013·Granted Jan 6, 2015·4 cites·9 claims
- 1688US7875454B2X-ray guided drug deliveryUNIV VANDERBILT·Filed 2006·Granted Jan 25, 2011·4 cites·22 claims
- 1788US7402392B2In vivo panning for ligands to radiation-induced moleculesUNIV VANDERBILT·Filed 2002·Granted Jul 22, 2008·24 cites·22 claims
- 1887US10086073B2Ligands to radiation-induced moleculesHALLAHAN DENNIS E·Filed 2016·Granted Oct 2, 2018·2 cites·13 claims
- 1983US5962424AMethods and compositions for targeting selectinsARCH DEV CORP·Filed 1995·Granted Oct 5, 1999·64 cites·25 claims
- 2080US7041653B2Gene transcription and ionizing radiation: methods and compositionsDANA FARBER CANCER INST INC·Filed 2000·Granted May 9, 2006·4 cites·16 claims
- 2179US6156736AGene transcription and ionizing radiation: methods and compositionsARCH DEV CORP·Filed 1998·Granted Dec 5, 2000·21 cites·41 claims
- 2277US8617521B2Phage antibodies to radiation-inducible neoantigensHALLAHAN DENNIS E·Filed 2011·Granted Dec 31, 2013·7 cites·8 claims
- 2373US6605712B1Gene transcription and ionizing radiation: methods and compositionsARCH DEV CORP·Filed 1992·Granted Aug 12, 2003·25 cites·35 claims
- 2472US9738725B2Antibodies to TIP-1UNIV WASHINGTON·Filed 2014·Granted Aug 22, 2017·1 cites·8 claims
- 2568US5817636AControl of gene expression by ionizing radiationARCH DEV CORP·Filed 1995·Granted Oct 6, 1998·21 cites·32 claims
- 2667US5641755ARegulation of x-ray mediated gene expressionARCH DEV CORP·Filed 1994·Granted Jun 24, 1997·31 cites·4 claims
- 2764US7919310B2Constitutive gene expression in conjunction with ionizing radiationUNIV CHICAGO·Filed 2008·Granted Apr 5, 2011·0 cites·4 claims
- 2860US8129356B2Bmx mediated signal transduction in irradiated vascular endotheliumHALLAHAN DENNIS E·Filed 2008·Granted Mar 6, 2012·0 cites·37 claims
- 2956US2012089017A1Ligands to radiation-induced moleculesHALLAHAN DENNIS E·Filed 2011·Application pending·0 cites
- 3056US2008014175A1Methods and Compositions for Viral Enhancement of Cell KillingUNIV CHICAGO·Filed 2007·Application pending·0 cites
- 3154US2005147591A1Methods and compositions for viral enhancement of cell killingFiled 2004·Application pending·0 cites
- 3253US10066008B2Monoclonal antibodies to human 14-3-3 epsilon and human 14-3-3 epsilon svUNIV WASHINGTON·Filed 2016·Granted Sep 4, 2018·0 cites·17 claims
- 3353US2006084697A1Pi3k antagonists as radiosensitizersHALLAHAN DENNIS E·Filed 2003·Application pending·0 cites
- 3452US8740762B2Specific inhibition of cPLA2 enhances the efficacy of radiotherapyHALLAHAN DENNIS E·Filed 2008·Granted Jun 3, 2014·0 cites·34 claims
- 3552US2003216337A1Composition and imaging methods for pharmacokinetic and pharmacodynamic evaluation of therapeutic delivery systemUNIV VANDERBILT·Filed 2003·Application pending·0 cites
- 3652US2006046271A1Assessment of cancer susceptibility to molecular targeted therapy by use of recombinant peptidesUNIV VANDERBILT·Filed 2005·Application pending·0 cites
- 3751US2003181377A1Inhibition of VEGF receptor signaling reverses tumor resistance to radiotherapyUNIV VANDERBILT·Filed 2003·Application pending·0 cites
- 3851US2024317885A1Anti-tax interacting protein-1 (tip1) binding moleculesMEDICAL GUIDANCE SYSTEMS LLC·Filed 2022·Application pending·0 cites
- 3949US2006058258A1Gene transcription and ionizing radiation: methods and compositionsDANA FARBER CANCER INST INC·Filed 2005·Application pending·0 cites
- 4047US10449261B2Compositions targeting radiation-induced molecules and methods of use thereofUNIV WASHINGTON·Filed 2015·Granted Oct 22, 2019·0 cites·19 claims
- 4147US2022259322A1Anti-grp78 antibodies and method of use thereofUNIV WASHINGTON·Filed 2020·Application pending·0 cites
- 4245US7592317B1Constitutive gene expression in conjuction with ionizing radiationUNIV CHICAGO·Filed 1994·Granted Sep 22, 2009·10 cites·30 claims
- 4345US2003219785A1Targeted drug delivery methodsUNIV VANDERBILT·Filed 2003·Application pending·0 cites
- 4444US11352436B2Antibodies to TIP1 and methods of use thereofHALLAHAN DENNIS·Filed 2018·Granted Jun 7, 2022·0 cites·14 claims
- 4543US2010135905A1Assessment of cancer susceptibility to molecular targeted therapy by use of recombinant peptidesHALLAHAN DENNIS E·Filed 2010·Application pending·0 cites
- 4642US2006079538A1Methods for inhibiting angiogenesisHALLAHAN DENNIS·Filed 2005·Application pending·0 cites
- 4734US6486170B1Phospholipase A2 inhibitors as mediators of gene expressionARCH DEV CORP·Filed 1994·Granted Nov 26, 2002·2 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when Dennis E. Hallahan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →